Israel’s MeMed (see here previously) reached a major milestone of more than 100,000 patients tested with its MeMed BV, the company’s flagship technology that accurately distinguishes between bacterial and viral infections in just 15 minutes.

https://www.ourcrowd.com/startup-news/memed-bv-surpasses-100000-patient-tests-underscoring-adoption-of-rapid-host-response-diagnostics